From: Prognostic nomogram for 30-day mortality of deep vein thrombosis patients in intensive care unit
Variables | Survival group | Death group | P value |
---|---|---|---|
 | 444 | 91 |  |
General condition | |||
 Age | 64.36 (± 15.43) | 71.51 (± 14.23) |  < 0.001 |
 Male | 278 (62.6%) | 53 (58.2%) | 0.507 |
 Admission type |  |  | 0.821 |
  Emergency | 424 (95.5%) | 88 (96.7%) |  |
  Elective | 19 (4.3%) | 3 (3.3%) |  |
  Urgent | 1 (0.2%) | 0 (0.0%) |  |
 Position of DVT |  |  | 0.079 |
  Unspecified | 70 (15.8%) | 23 (25.3%) |  |
  Proximal | 273 (61.5%) | 52 (57.1%) |  |
  Distal | 101 (22.7%) | 16 (17.6%) |  |
 Acute DVT | 420 (94.6%) | 89 (97.8%) | 0.304 |
 Heartrate (bpm) | 88.38 (± 15.72) | 92.40 (± 19.41) | 0.036 |
 Systolic blood pressure (mmHg) | 119.51 (± 15.14) | 109.95 (± 14.15) | < 0.001 |
 Diastolic blood pressure (mmHg) | 64.69 (± 10.63) | 58.60 (± 10.30) | < 0.001 |
 Respiratory rate (1/min) | 19.67 (± 4.08) | 21.33 (± 4.81) | 0.001 |
 Temperature ( °C) | 36.80 (± 0.61) | 36.53 (± 0.59) |  < 0.001 |
 spO2 (%) | 97.16 (± 1.76) | 96.75 (± 2.88) | 0.075 |
 Glucose (mg/dl) | 136.15 (± 40.16) | 142.66 (± 48.16) | 0.185 |
Comorbidity | |||
 Infection | 253 (57.0%) | 70 (76.9%) | 0.001 |
 Sepsis | 39 (8.8%) | 33 (36.3%) |  < 0.001 |
 Organ dysfunction | 222 (50.0%) | 70 (76.9%) |  < 0.001 |
 Congestive heart failure | 79 (17.8%) | 26 (28.6%) | 0.027 |
 Cardiac arrhythmias | 92 (20.7%) | 34 (37.4%) | 0.001 |
 Valvular disease | 22 (5.0%) | 5 (5.5%) | 1 |
 Pulmonary circulation disorder | 104 (23.4%) | 25 (27.5%) | 0.491 |
 Peripheral vascular disease | 33 (7.4%) | 11 (12.1%) | 0.207 |
 Hypertension | 44 (9.9%) | 19 (20.9%) | 0.005 |
 Paralysis | 33 (7.4%) | 5 (5.5%) | 0.666 |
 Neurological disease | 63 (14.2%) | 10 (11.0%) | 0.521 |
 Chronic pulmonary disease | 72 (16.2%) | 29 (31.9%) | 0.001 |
 Diabetes | 107 (24.1%) | 21 (23.1%) | 0.942 |
 Hypothyroidism | 46 (10.4%) | 11 (12.1%) | 0.764 |
 Renal failure | 51 (11.5%) | 22 (24.2%) | 0.002 |
 Liver disease | 22 (5.0%) | 5 (5.5%) | 1 |
 Lymphoma | 5 (1.1%) | 4 (4.4%) | 0.078 |
 Metastatic cancer | 39 (8.8%) | 20 (22.0%) | 0.001 |
 Solid tumor | 20 (4.5%) | 6 (6.6%) | 0.564 |
 Obesity | 32 (7.2%) | 10 (11.0%) | 0.313 |
 Blood loss anemia | 12 (2.7%) | 5 (5.5%) | 0.291 |
 Alcohol abuse | 32 (7.2%) | 3 (3.3%) | 0.254 |
 Depression | 48 (10.8%) | 7 (7.7%) | 0.482 |
Laboratory Indicators | |||
 RDW (%) | 15.00 (14.00, 16.00) a | 16.00 (14.50, 17.00) a |  < 0.001 |
 Lymphocyte (%) | 13.67 (± 9.04) | 9.26 (± 7.22) |  < 0.001 |
 Monocyte (%) | 4.00 (3.00, 6.00) a | 4.00 (3.00, 5.75) a | 0.252 |
 Neutrophil (%) | 78.22 (± 13.16) | 81.72 (± 12.90) | 0.025 |
 Hematocrit (%) | 34.53 (± 6.81) | 32.97 (± 6.77) | 0.047 |
 White blood cell count (K/μL) | 11.58 (± 5.96) | 14.09 (± 8.29) | 0.001 |
 Platelet count (K/μL) | 254.05 (± 127.01) | 273.23(± 161.47) | 0.213 |
 Potassium (mEq/L) | 4.27 (± 0.83) | 4.34 (± 0.74) | 0.472 |
 Sodium (mEq/L) | 138.33 (± 4.89) | 137.47 (± 5.88) | 0.145 |
 Anion gap (mEq/L) | 15.24 (± 3.76) | 15.44 (± 3.94) | 0.653 |
 Bicarbonate (mEq/L) | 24.29 (± 4.19) | 23.77 (± 5.12) | 0.303 |
 Chloride (mEq/L) | 103.09 (± 6.38) | 102.80 (± 6.79) | 0.697 |
 Blood urea nitrogen (mg/dL) | 24.06 (± 17.17) | 34.06 (± 22.25) |  < 0.001 |
 Creatinine (mg/dL) | 1.00 (0.80, 1.30) a | 1.20 (0.70, 1.95) a | 0.066 |
 Albumin (g/dL) | 3.14 (± 0.66) | 2.70 (± 0.71) | < 0.001 |
 Hemoglobin (g/dL) | 11.66 (± 2.40) | 10.95 (± 2.34) | 0.01 |
 Lactate (mmol/L) | 1.70 (1.30, 2.60)a | 2.30 (1.50, 3.00)a | 0.008 |
 PTT (s) | 37.90 (± 26.91) | 37.35 (± 24.97) | 0.857 |
 PT (s) | 16.84 (± 12.45) | 20.31 (± 20.61) | 0.034 |
 NLR | 7.12 (3.81, 12.00)a | 12.29 (5.36, 19.96)a | < 0.001 |
 LMR | 2.79 (1.69, 4.32)a | 2.11 (1.08, 3.26)a | 0.001 |
Severity scores | |||
 OASIS | 31.20 (± 8.29) | 37.84 (± 9.84) | < 0.001 |
 SAPSII | 33.43 (± 12.54) | 48.66 (± 15.30) | < 0.001 |
 SOFA | 3.44 (± 2.67) | 5.97 (± 4.03) | < 0.001 |